<DOC>
	<DOCNO>NCT00906646</DOCNO>
	<brief_summary>This prospective randomise trial metabolic therapy include antioxidant cellular energiser determine whether therapy could improve result cardiac surgery . The hypothesis metabolic therapy could improve clinical recovery .</brief_summary>
	<brief_title>Preparation Patients Cardiac Surgery</brief_title>
	<detailed_description>Objective Perioperative therapy antioxidant metabolic substrates potential reduce oxidative stress improve recovery cardiac surgery , particularly elderly high risk case . The aim study assess effect perioperative metabolic therapy biochemical clinical level cardiac surgical patient . Methods Patients ( n = 117 , mean age 65 Â± 1.0 year , 74 % male ) undergo elective coronary artery bypass graft ( CABG ) and/or valve surgery randomize receive minimum 2 week one month surgery , either metabolic therapy ( coenzyme Q10 , magnesium orotate , lipoic acid , omega-3 fatty acid selenium ) placebo . Biochemical clinical outcome assess .</detailed_description>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>patient undergo elective coronary artery bypass graft ( CABG ) and/or valve surgery urgent emergency surgery NYHA class IV heart failure take antioxidant supplement previous month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>cardiac</keyword>
	<keyword>surgery</keyword>
	<keyword>metabolic</keyword>
	<keyword>supplement</keyword>
	<keyword>antioxidant</keyword>
</DOC>